Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia

Author:

Staber Philipp B.1ORCID,Herling Marco234,Bellido Mar5,Jacobsen Eric D.6,Davids Matthew S.6,Kadia Tapan Mahendra7,Shustov Andrei8,Tournilhac Olivier9ORCID,Bachy Emmanuel10,Zaja Francesco11,Porkka Kimmo12ORCID,Hoermann Gregor1314,Simonitsch-Klupp Ingrid15,Haferlach Claudia16,Kubicek Stefan1718ORCID,Mayerhoefer Marius E.1920,Hopfinger Georg21,Jaeger Ulrich1ORCID,Dearden Claire22

Affiliation:

1. Division of Hematology and Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria;

2. Department of Internal Medicine, Center for Integrated Oncology Aachen-Bonn-Cologne-Duesseldorf, and

3. Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases, University of Cologne, Cologne, Germany;

4. Center for Molecular Medicine, University of Cologne, Cologne, Germany;

5. Hematology Department, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands;

6. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;

7. Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX;

8. Seattle Cancer Care Alliance, University of Washington, Seattle, WA;

9. Centre Hospitalier Universitaire Estaing, Clermont-Ferrand, France;

10. Department of Hematology, Hospices Civils de Lyon, Lyon, France;

11. S.C. Ematologia Azienda Sanitaria Universitaria Integrata, Trieste, Italy;

12. Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland;

13. Central Institute of Medical and Chemical Laboratory Diagnostics, University Hospital Innsbruck, Innsbruck, Austria;

14. Department of Laboratory Medicine and

15. Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria;

16. Munich Leukemia Laboratory, Munich, Germany;

17. CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria;

18. Christian Doppler Laboratory for Chemical Epigenetics and Anti-Infectives, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria;

19. Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria;

20. Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY;

21. Division of Blood and Marrow Transplantation, Department of Medicine I, Medical University of Vienna, Vienna, Austria; and

22. The Royal Marsden Hospital, NHS Foundation Trust, London, United Kingdom

Abstract

Abstract In a Special Report, the T-PLL International Study group presents consensus criteria for the diagnosis, staging, and treatment response assessment of patients with T-cell prolymphocytic leukemia.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Cited by 80 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3